Carter Dan, Bardan Eytan, Dickman Ram
Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer (Dan Carter, Eytan Bardan), Israel.
Sackler faculty of Medicine, Tel Aviv University, Tel Aviv (Dan Carter, Eytan Bardan, Ram Dickman), Israel.
Ann Gastroenterol. 2018 Jan-Feb;31(1):71-76. doi: 10.20524/aog.2017.0214. Epub 2017 Nov 16.
Although guidelines have been published for the treatment of chronic constipation, little is known about the actual treatment strategies, the definitions of drug efficacy, the parameters for drug selection, and the conceived limitations of the available treatments. The purpose of this study was to address these issues by comparing treatment strategies among gastroenterology specialists (GIs) and general practitioners (GPs).
An internet survey was sent nationwide and at random to GIs and GPs in order to define treatment strategies, drug efficacy, main parameters for drug selections and the main limitations of the available drug therapy.
Forty GIs and 132 GPs answered the survey. The maximal sample error was ±13.4% and ±8.8%. Treatment strategies varied considerably between GPs and GIs. The major parameters for drug selection were related to drug safety among GIs and to clinical outcome among GPs. The conceived limitations of drug therapy included lack of experience and unwanted side effects.
Awareness of the possible treatment options and the recommended order of prescription differs between GIs and GPs. There are still unmet needs for optimizing the treatment for chronic constipation.
尽管已经发布了慢性便秘的治疗指南,但对于实际的治疗策略、药物疗效的定义、药物选择的参数以及现有治疗方法的预期局限性知之甚少。本研究的目的是通过比较胃肠病学专家(GI)和全科医生(GP)的治疗策略来解决这些问题。
在全国范围内随机向胃肠病学专家和全科医生发送了一项网络调查,以确定治疗策略、药物疗效、药物选择的主要参数以及现有药物治疗的主要局限性。
40名胃肠病学专家和132名全科医生回答了调查。最大抽样误差分别为±13.4%和±8.8%。全科医生和胃肠病学专家之间的治疗策略差异很大。胃肠病学专家选择药物的主要参数与药物安全性有关,而全科医生则与临床结果有关。药物治疗的预期局限性包括缺乏经验和不良副作用。
胃肠病学专家和全科医生对可能的治疗选择和推荐的处方顺序的认识有所不同。在优化慢性便秘治疗方面仍有未满足的需求。